Skip to main navigation Skip to search Skip to main content

A phase 3 open label study evaluating the long term safety and efficacy of VX-121 combinatin therapy in subjects with cyctic fibrosis

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date02/21/23 → 02/20/27

Funding

  • Vertex Pharmaceuticals Incorporated: $97,508.69